The program provides a ready-made structure, support tools, simulation methods, and GS1 Standards expertise. Participants also benefit from a collaborative environment for sharing experiences, lessons learned, outcomes, and best practices across all pilot activities.
The 2015 Readiness Pilot program is based on the concepts developed by the GS1 Healthcare US Traceability Adoption Workgroup, the Secure Supply Chain Task Force, and 2015 Readiness Program members to support industry-wide implementation. A key component of this work is the U.S. Pharmaceutical Industry Reference Model (IRM-Rx), which includes the simulation of business processes and data collection across the entire supply chain using GS1 Standards for serialization and visibility, as well as an analysis engine that can be used to assess your results.
Advantages of 2015 Readiness Pilots
• Get started quickly using a ready-made pilot structure
• Join established pilots
• Design your own pilot based on individual readiness and needs
• Easily manage your pilot with the tools and resources provided
• Find pilot partners through GS1’s industry network
• Connect with industry members that can share experiences specific to your pilot
• Learn from other pilots
Support for your pilot:
• Access GS1 experts for standards-related implementation questions
• Test your readiness against the Industry Reference Model and explore the results with the analysis engine
• Leverage a virtual pilot partner for hard-to-test processes such as recalls, serial number discrepancies, concealed shortages, and more
• Gain insights and share learnings across all 2015 Readiness Pilot participants to support industry-wide implementation
2015 Readiness Pilot examples Include:
• Serializing your products
• Test your case and pallet aggregation
• Pedigree data exchange for recalls, returns, and forward logistics
Single-tier and multi-tier scenarios
Share your results
When you contribute what you learn back to GS1 US, the entire industry learns more quickly, solidifying standards and reducing costs at every step of the supply chain. Much of what you read in the “Lessons learned” section of this Playbook came right from those pilot results, and would not have been possible without those companies having shared what they have learned. Please consider doing the same.
To learn more, please contact Bob Celeste, Director, Healthcare, GS1 Healthcare US, at rceleste@GS1US.org.
Liked this article? Download the entire playbook here.
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
